ARCHIVES

New Jersey Insurers To Cover Patient Care Costs In Trials.

This article is from The Cancer Letter archive.

Vol. 26 No. 02 | January 14, 2000

Download PDF Visit The Full Archive

Related Articles

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

August 26, 2011

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

NCI T Use Ames Test In Carcinogenesis Testing Program

December 3, 1976